Active pathways of the LUSC risk groups, are highly related to cancer pathways such as PI3K-Akt signaling pathway, Ras signaling pathway, Small-cell lung cancer, Proteoglycans in cancer and Rap1 signaling pathway (Figure 6A,B). This evidence concerns the gene AKT1 and small cell lung carcinoma.